India Influenza Vaccine Market Segmentation Insights, From USD 26.76 Million in 2024 with 7.45% CAGR

The India Influenza Vaccine Market reached USD 26.76 million in 2024. Experts expect it to expand to USD 41.28 million by 2030. This growth follows a compound annual rate of 7.45 percent over the period. Several factors support this rise, including better access to vaccines and stronger health systems. Urban areas see higher demand due to busy lifestyles and close living conditions. Rural regions catch up as distribution improves. Seasonal flu cases remind people of the need for protection each year. Health workers push for wider coverage to cut hospital visits. This market serves millions, from young children to older adults. Companies invest in production to meet rising needs. Government spending on health aids this trend. Private clinics add to the supply chain. Overall, the forecast points to steady progress in vaccine use across the country.

Public knowledge about influenza risks grows each year in India. People learn about symptoms like fever, cough, and fatigue that flu brings. This knowledge leads to more vaccinations, especially in cities. Schools teach children about health habits, including shots. Families with sick members seek vaccines first. News stories highlight flu outbreaks in winter months. Doctors advise patients with weak lungs to get protected. All these efforts build a habit of yearly shots. The market benefits from this shift in behavior. Sales rise as more groups join in. Low-cost options make it easier for average families. Clinics offer quick services to encourage uptake. This driver stands out as a main force behind the market's expansion.


Browse market data Figures spread through 185+ Pages and an in-depth TOC on "India Influenza Vaccine Market”- https://www.techsciresearch.com/report/india-influenza-vaccine-market/28295.html

1. INDIA INFLUENZA VACCINE MARKET TRENDS AND PROJECTIONS,
MARKET SIZE USD 41.28 MILLION BY 2030 AT 7.45% CAGR

2. Market Size and Growth Forecast

The India Influenza Vaccine Market reached USD 26.76 million in 2024. Experts expect it to
expand to USD 41.28 million by 2030. This growth follows a compound annual rate of 7.45 percent
over the period. Several factors support this rise, including better access to vaccines and stronger
health systems. Urban areas see higher demand due to busy lifestyles and close living conditions.
Rural regions catch up as distribution improves. Seasonal flu cases remind people of the need for
protection each year. Health workers push for wider coverage to cut hospital visits. This market
serves millions, from young children to older adults. Companies invest in production to meet
rising needs. Government spending on health aids this trend. Private clinics add to the supply
chain. Overall, the forecast points to steady progress in vaccine use across the country.


Key Drivers of Market Growth
Public knowledge about influenza risks grows each year in India. People learn about symptoms
like fever, cough, and fatigue that flu brings. This knowledge leads to more vaccinations,
especially in cities. Schools teach children about health habits, including shots. Families with sick
members seek vaccines first. News stories highlight flu outbreaks in winter months. Doctors
advise patients with weak lungs to get protected. All these efforts build a habit of yearly shots.
The market benefits from this shift in behavior. Sales rise as more groups join in. Low-cost options

3. make it easier for average families. Clinics offer quick services to encourage uptake. This driver
stands out as a main force behind the market's expansion.


Browse market data Figures spread through 185+ Pages and an in-depth TOC on "India
Influenza Vaccine Market”- https://www.techsciresearch.com/report/india-influenza-
vaccine-market/28295.html


Government programs play a big role in this growth. The Universal Immunization Programme
includes flu shots for key groups. It targets infants, older people, and pregnant women. The
Integrated Disease Surveillance Programme tracks flu cases nationwide. Officials use data to plan
vaccine supplies. Campaigns run in villages and towns to spread facts. Free doses go to those in
need. This work reduces illness rates over time. Partnerships with local leaders help reach
remote areas. Training for health workers ensures safe delivery. These steps create trust in
vaccines. As a result, more people line up for shots each season. The market sees direct gains
from these actions.

4. The COVID-19 outbreak changed views on respiratory health. People feared similar infections
after the pandemic. Many turned to flu vaccines for extra safety. Hospitals saw lines for shots in
2020 and beyond. This event raised questions about prevention. Families stocked up on health
items, including vaccines. Media shared stories of recovery through early care. This awareness
lingers, boosting demand year after year. Vaccine makers ramped up output to match needs.
New types came out to cover more strains. The link between COVID lessons and flu protection
drives ongoing sales. Health policies now stress combined defenses against viruses.

Role of Private Sector and Media

Private hospitals and companies add to vaccine access. They run drives for workers and families
in big cities. Offices set up on-site clinics for easy shots. This targets busy adults who skip public
centers. Costs stay low through bulk buys. Urban dwellers value this convenience. Partnerships
with drug stores expand reach. Events at malls draw crowds for free checks and vaccines. These
efforts fill gaps in government services. The market grows as private options attract middle-class
buyers. Quality assurance builds loyalty among users.
Media tools spread facts fast across India. Social networks share tips from doctors on flu risks.
Videos explain how vaccines work in simple terms. Influencers post about their own shots to
inspire followers. TV ads run during peak seasons. Websites offer info on where to get
vaccinated. This mix reaches young and old alike. People search online for symptoms and

5. solutions. Campaigns use local languages for better understanding. All this leads to higher
turnout at clinics. The market thrives on this flow of information. Engagement rates climb with
each post or show.

Market Segmentation Analysis

The market breaks down into types like inactivated and live attenuated vaccines. Inactivated ones
grow fastest due to safety for all ages. They suit people with weak immune systems or pregnancy.
Providers prefer them for wide use. Government buys large amounts for programs. Awareness of
lung issues like asthma pushes demand. Quadrivalent versions cover four strains, adding value.
This segment leads in sales growth. Users trust the strong response it gives. Availability in clinics
helps adoption.

By indication, quadrivalent vaccines dominate in 2024. They protect against more flu types than
trivalent ones. Families choose them for full coverage. Pediatric and adult groups both use them.
Injection remains the top route, easy for most people. Nasal sprays offer choices for kids who fear
needles. Distribution happens through hospitals, pharmacies, and government supplies. Hospitals
lead as trusted spots for shots. Regions split into north, south, east, and west. Each shows unique
patterns in use.

6. Download Free Sample Report - https://www.techsciresearch.com/sample -
report.aspx?cid=28295


Regional Focus: North India's Expansion
North India grows fastest in 2024. Cities like Delhi and Lucknow see high demand. Winter cold
and pollution worsen flu risks. People face smog that hurts lungs daily. Government drives target
these areas with free vaccines. Private initiatives add to the push. Infrastructure improves with
new clinics. Access grows in smaller towns too. Expenditure on health rises here. Networks for
delivery work well. This region outpaces others in adoption rates. West India holds the largest
share overall, with strong systems in Mumbai. Yet north's speed stands out. Factors like
awareness and programs fuel this.

South and east regions follow with steady gains. Urban hubs drive most sales. Rural challenges
slow some areas, but efforts continue.

7. Market Segmentation:

• India Influenza Vaccine Market, By Type:
o Inactivated
o Live Attenuated
• India Influenza Vaccine Market, By Indication:
o Quadrivalent
o Trivalent
• India Influenza Vaccine Market, By Age Group:
o Pediatric
o Adult
• India Influenza Vaccine Market, By Route of Administration:
o Injection
o Nasal Spray
• India Influenza Vaccine Market, By Distribution Channel:
o Hospitals & Pharmacies
o Government & Institutional Supply
o Others

8. Major Companies and Recent Updates

• GSK PLC
• Pfizer Inc
• Merck & Co Inc
• Viatris Inc
• AstraZeneca PLC
• Sanofi SA
• Serum Institute of India
• Bharatbiotech International Ltd

Sanofi SA offers wide options. Serum Institute of India produces local supplies. Bharat Biotech
International Ltd focuses on new types. These firms compete on price and quality. They invest in
research for better vaccines. Partnerships with government boost their reach.

Recent steps include new launches. In July 2024, a project started for bird flu vaccines in low-
income spots. March 2024 saw Cadiflu Tetra release for broad protection. Another firm got

9. approval for child vaccines. October 2023 brought a nasal option without needles. These changes
improve choices for users. Market shares shift with each advance. Companies eye rural markets
next.

Why You Should Check Out This Report
1. It provides exact market size data from 2024 to 2030 for planning.
2. You get forecasts with 7.45 percent CAGR to spot growth chances.
3. Drivers like awareness and programs appear in detail for strategy.
4. Segmentation by type and region helps target specific areas.
5. Regional breakdowns show where to focus efforts, like north India.
6. Company profiles offer views on leaders and their moves.
7. Recent developments keep you updated on new vaccines and trends.


The India Influenza Vaccine Market shows promise for health gains. More vaccines mean fewer
sick days for workers. Children stay in school longer without flu breaks. Older adults avoid
severe cases. Systems adapt to seasonal needs. Distribution reaches farther each year. Costs drop
with local production. Trust builds through safe use. This path leads to better outcomes for all.

10. Download Free Sample Report - https://www.techsciresearch.com/sample -
report.aspx?cid=28295

Recent Published Reports -

Pediatric Diabetes Management Market - https://www.techsciresearch.com/report/pediatric-
diabetes-management-market/30511.html
Elder Care Assistive Robots Market - https://www.techsciresearch.com/report/elder-care-
assistive-robots-market/30514.html
Multiomics Services Market - https://www.techsciresearch.com/report/multiomics-services-
market/30515.html
Topical Cyanoacrylates Market - https://www.techsciresearch.com/report/topical-
cyanoacrylates-market/30516.html
Vascular Access Procedures Market - https://www.techsciresearch.com/report/vascular-access-
procedures-market/30435.html

11. About Us:
TechSci Research is a management consulting firm focused on market research and advisory
solutions, serving clients across industries worldwide.
At its core, TechSci stands on three values: value, integrity, and insight. Backed by a team of
experienced industry professionals, the firm helps clients discover new opportunities, identify
growth drivers, and find smarter ways to gain market share. Instead of following trends, TechSci
empowers its clients to set them.
Unlike traditional research models, TechSci combines decades of expertise with advanced
technology to deliver sharper, more practical insights. Its reports go beyond raw data—
presenting information in a clear, interactive format that clients can actually use to make informed
decisions.

Contact
420 Lexington Avenue,
Suite 300, New York, NY,

12. United States, 10170
Tel: [phone]
Email: [email protected]
Website: https://www.techsciresearch.com